Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1961 1
1962 2
1963 1
1965 1
1966 3
1967 1
1968 2
1969 2
1970 1
1972 3
1973 1
1974 4
1975 2
1976 3
1977 3
1978 2
1979 3
1980 9
1981 4
1982 8
1983 3
1984 9
1985 10
1986 14
1987 11
1988 16
1989 4
1990 9
1991 7
1992 7
1993 10
1994 21
1995 10
1996 12
1997 8
1998 13
1999 17
2000 17
2001 10
2002 26
2003 18
2004 20
2005 25
2006 26
2007 26
2008 38
2009 32
2010 26
2011 26
2012 24
2013 26
2014 25
2015 22
2016 31
2017 33
2018 29
2019 40
2020 52
2021 62
2022 45
2023 57
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

906 results

Results by year

Filters applied: . Clear all
Page 1
Iron chelation therapy.
Bruzzese A, Martino EA, Mendicino F, Lucia E, Olivito V, Bova C, Filippelli G, Capodanno I, Neri A, Morabito F, Gentile M, Vigna E. Bruzzese A, et al. Among authors: martino ea. Eur J Haematol. 2023 May;110(5):490-497. doi: 10.1111/ejh.13935. Epub 2023 Feb 8. Eur J Haematol. 2023. PMID: 36708354 Review.
Isatuximab in multiple myeloma.
Martino EA, Bruzzese A, Iaccino E, Mendicino F, Mimmi S, Lucia E, Olivito V, Neri A, Morabito F, Vigna E, Gentile M. Martino EA, et al. Expert Opin Biol Ther. 2023 Apr;23(4):315-318. doi: 10.1080/14712598.2023.2193289. Epub 2023 Mar 24. Expert Opin Biol Ther. 2023. PMID: 36943846 No abstract available.
Elotuzumab in multiple myeloma.
Bruzzese A, Martino EA, Vigna E, Iaccino E, Mendicino F, Lucia E, Olivito V, Filippelli G, Neri A, Morabito F, Gentile M. Bruzzese A, et al. Among authors: martino ea. Expert Opin Biol Ther. 2023 Jan;23(1):7-10. doi: 10.1080/14712598.2022.2145882. Epub 2022 Nov 14. Expert Opin Biol Ther. 2023. PMID: 36373842 No abstract available.
Teclistamab-cqyv in multiple myeloma.
Martino EA, Bruzzese A, Labanca C, Mendicino F, Lucia E, Olivito V, Neri A, Morabito F, Vigna E, Gentile M. Martino EA, et al. Eur J Haematol. 2024 Mar;112(3):320-327. doi: 10.1111/ejh.14121. Epub 2023 Oct 17. Eur J Haematol. 2024. PMID: 37848191 Review.
[Amiodarone-induced thyrotoxicosis].
Bogazzi F, Tomisti L, Di Bello V, Martino E. Bogazzi F, et al. Among authors: martino e. G Ital Cardiol (Rome). 2017 Mar;18(3):219-229. doi: 10.1714/2674.27399. G Ital Cardiol (Rome). 2017. PMID: 28398380 Review. Italian.
Tagraxofusp in myeloid malignancies.
Bruzzese A, Martino EA, Labanca C, Mendicino F, Lucia E, Olivito V, Neri A, Imovilli A, Morabito F, Vigna E, Gentile M. Bruzzese A, et al. Among authors: martino ea. Hematol Oncol. 2024 Jan;42(1):e3234. doi: 10.1002/hon.3234. Epub 2023 Oct 17. Hematol Oncol. 2024. PMID: 37846131 Review.
Myelodysplastic syndromes with ring sideroblasts.
Bruzzese A, Vigna E, Martino EA, Mendicino F, Lucia E, Olivito V, Bova C, Barbato A, Filippelli G, Capodanno I, Neri A, Morabito F, Gentile M. Bruzzese A, et al. Among authors: martino ea. Hematol Oncol. 2023 Oct;41(4):612-620. doi: 10.1002/hon.3125. Epub 2023 Feb 26. Hematol Oncol. 2023. PMID: 36794650 Review.
Belantamab mafodotin in multiple myeloma.
Martino EA, Bruzzese A, Iaccino E, Labanca C, Mendicino F, Mimmi S, Lucia E, Olivito V, Neri A, Morabito F, Vigna E, Gentile M. Martino EA, et al. Expert Opin Biol Ther. 2023 Jul-Dec;23(11):1043-1047. doi: 10.1080/14712598.2023.2218543. Epub 2023 May 27. Expert Opin Biol Ther. 2023. PMID: 37227998 No abstract available.
906 results